Wealthspire Advisors (Maryland)’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AAMU
FMI
DSA
Wealthspire Advisors (Maryland)'s DGX Position: Q2 2019 in Review
Wealthspire Advisors (Maryland) sold out of Quest Diagnostics (DGX) in Q2 2019, closing a stake of 1,198 shares — an estimated $108K sold.
Wealthspire Advisors (Maryland) first reported a position in DGX in Q4 2015 and held it in 14 quarters. The position peaked at $108K in Q1 2019. 654 funds tracked by Wall St. Rank hold DGX as of Q2 2019.
- Wealthspire Advisors (Maryland) reported no remaining Quest Diagnostics position as of Q2 2019 after selling out during the quarter.
- Wealthspire Advisors (Maryland) sold 1,198 Quest Diagnostics shares in Q2 2019, an estimated $108K.
- Wealthspire Advisors (Maryland) first reported a position in Quest Diagnostics in Q4 2015 and held it in 14 quarters.
- Wealthspire Advisors (Maryland)'s Quest Diagnostics position peaked at $108K in Q1 2019.
- 654 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2019.
Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.